NASDAQ:CYRX
CryoPort Stock News
$18.12
+0.770 (+4.44%)
At Close: Mar 27, 2024
Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript
08:48pm, Tuesday, 12'th Mar 2024
Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates
06:31pm, Tuesday, 12'th Mar 2024
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.24 per share a year ago.
Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 15'th Feb 2024
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy CryoPort, Inc. (CYRX) After Golden Cross?
10:56am, Tuesday, 13'th Feb 2024
After reaching an important support level, CryoPort, Inc. (CYRX) could be a good stock pick from a technical perspective. CYRX recently experienced a "golden cross" event, which saw its 50-day simple
Cryoport, Inc. (CYRX) Q3 2023 Earnings Call Transcript
12:18am, Thursday, 09'th Nov 2023
Cryoport, Inc. (NASDAQ:CYRX ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefan
New Strong Sell Stocks for August 21st
09:01am, Monday, 21'st Aug 2023
ALPMY, CYRX and DRCT have been added to the Zacks Rank #5 (Strong Sell) List on August 21, 2023.
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
06:59pm, Wednesday, 09'th Aug 2023
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.17 per share a year ago.
Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment
09:05am, Friday, 14'th Jul 2023
Cryoport released preliminary Q2 results, projecting sales to fall behind The Street's estimates. Lower demand for Cryoport's capital equipment and delays in initiating clinical trials are key reasons
Why Shares of Cryoport are Tumbling Thursday
11:17am, Thursday, 13'th Jul 2023
Cryoport downgraded annual guidance. The company has seen a slowdown in orders from gene therapy and cell therapy clients.
Why Is CryoPort (CYRX) Stock Down 26% Today?
09:04am, Thursday, 13'th Jul 2023
CryoPort (NASDAQ: CYRX ) stock is falling on Thursday after the cell and gene therapy products company released preliminary results for the second quarter of 2023. The bad news for investors in CYRX s
Cryoport shares slide 29% after revenue warning
08:07am, Thursday, 13'th Jul 2023
Shares of Cryoport Inc. CYRX, +3.58% fell 29% in premarket trading on Thursday after the life-science logistics company issued a revenue warning, noting weaker than expected global demand for capital
Cryoport: A Strong Player In Cold-Chain Logistics With Solid Growth Prospects
09:42pm, Tuesday, 04'th Jul 2023
Cryoport, Inc. is well-positioned to benefit from the growth in the cell and gene therapy industry due to its dominant position in the cold-chain logistics market and potential for substantial revenue
Cryoport, Inc. (CYRX) Q1 2023 Earnings Call Transcript
03:23am, Friday, 05'th May 2023
Cryoport, Inc. (NASDAQ:CYRX ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefanovich
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
07:44pm, Thursday, 04'th May 2023
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.31 per share a year ago.
Cryoport, Inc. (CYRX) Q4 2022 Earnings Call Transcript
10:04pm, Thursday, 23'rd Feb 2023
Cryoport, Inc. (NASDAQ:CYRX ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert St